Today we offer four items of Covid-19 news: a county-level dashboard of dangerousness; new discoveries on how the virus spreads so effectively and why it inhibits long-term immunity; and at-home saliva testing. Plus the accustomed frippery. Why illness may not … Continue reading →
We have been writing about potential vaccines in late-stage trials — prophylactics intended to prevent Covid-19 disease and, ideally, infection with SARS-Cov-2. Another class of drugs is the therapeutics, such as the Regeneron “cocktail” the President received. The vaccines from … Continue reading →
The Update has gone semi-weekly. Herewith three more items of pandemic news you may have missed recently: the next pandemic; the duration of immunity; and two new metrics that may portend severe Covid-19. Plus a frippery. Two New Metrics That … Continue reading →
Herewith three items of Covid-19 news you may have missed this week: Pfizer’s timeline for EUA application, normally apolitical science publications criticize the Trump administration, and the $16T cost of the pandemic in the US. Plus the accustomed frippery. Pfizer … Continue reading →
Repeat infections with Covid-19 are back in the news: a Nevada man’s case was published in The Lancet, and an elderly, immune-compromised woman in the Netherlands died after a second infection. Still, there is little cause to worry. We touched … Continue reading →
Herewith three items of Covid-19 news you may have missed this week: Neurologic symptoms are common, wrinkles in vaccine distribution, and a tracker for the White House superspreader events. Plus the accustomed frippery. Neurologic symptoms are common A study in … Continue reading →
Herewith three items of Covid-19 news you may have missed this week: the FDA wants more AstraZeneca data, Operation Warp Speed’s military staffing, and a deep dive into the vaccine testing process. Plus a brace of fripperies. FDA wants more … Continue reading →
We’re going to be stringing together Covid-19 and the immune system’s response to it with genes we inherited from Neanderthals. Bear with us. First, let’s look at a paper outlining a genetic defect that results in sub-par production of one … Continue reading →
Herewith three items of Covid-19 news you may have missed this week: viral loads are falling; glasses might help; and dogs sniff for Covid. Plus the accustomed frippery. Viral loads are falling ICU admissions and death rates from Covid-19 have … Continue reading →
Light at the energetic end of the ultraviolet spectrum has been demonstrated to disable viruses (including SARS-CoV-2) in air and on surfaces, without harming any humans present. Manufacturers of far-UVC light sources are ramping up production. News of this development … Continue reading →
